Cost-Utility Analysis of Bosutinib for Previously Treated Chronic Myeloid Leukemia (Cml) In Portugal. [electronic resource]
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research Nov 2014
- A533 p. digital